Lung Cancer Metastasis

Lung cancer is one of leading cancer-related causes of mortality worldwide. The propensity for metastasis in this disease undoubtedly contributes to the low survival rate and final poor outcome of patients. Lung cancer metastasis involves specific molecular pathways that confer the cancer cells abilities to survive in circulation, be motile, and form new tumors. Recent evidences have widened the understanding of cancer disseminating basis and emphasized the role of genetic and epigenetic imperfections, epithelial to mesenchymal transition, and cancer stem cells. The present chapter aims to illustrate metastatic processes of lung cancer, shedding more light on such key molecular paradigms. A deeper understanding of the mechanisms of lung cancer metastasis may lead to novel strategies in cancer preventive and therapeutic approaches.

[1]  N. Hynes,et al.  ErbB‐2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling , 1997, The EMBO journal.

[2]  S. Xiong,et al.  Differential Expression of CXCR4 Is Associated with the Metastatic Potential of Human Non–Small Cell Lung Cancer Cells , 2005, Clinical Cancer Research.

[3]  K. Gravdal,et al.  A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate Cancer , 2007, Clinical Cancer Research.

[4]  Qiang Yu,et al.  Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis , 2004, Oncogene.

[5]  B. Han,et al.  Wnt blockers inhibit the proliferation of lung cancer stem cells , 2015, Drug design, development and therapy.

[6]  T. Turpeenniemi‐Hujanen,et al.  Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker. , 2000, Anticancer research.

[7]  M. Maggiolini,et al.  Caveolin-1 silencing arrests the proliferation of metastatic lung cancer cells through the inhibition of STAT3 signaling. , 2012, Cellular signalling.

[8]  M. I. Ramirez,et al.  Increased PEA3/E1AF and decreased Net/Elk-3, both ETS proteins, characterize human NSCLC progression and regulate caveolin-1 transcription in Calu-1 and NCI-H23 NSCLC cell lines. , 2009, Carcinogenesis.

[9]  C. Gondi,et al.  Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non–small cell lung cancer cells , 2005, Molecular Cancer Therapeutics.

[10]  Changli Wang,et al.  Hedgehog/Gli promotes epithelial-mesenchymal transition in lung squamous cell carcinomas , 2014, Journal of experimental & clinical cancer research : CR.

[11]  Ying Zheng,et al.  Nicotine stimulates human lung cancer cell growth by inducing fibronectin expression. , 2007, American journal of respiratory cell and molecular biology.

[12]  J. Grandis,et al.  Signaling through the epidermal growth factor receptor during the development of malignancy. , 2004, Pharmacology & therapeutics.

[13]  Michael Gibson,et al.  Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes , 2013, Molecular Cancer.

[14]  Kwan-Kyu Park,et al.  Epithelial-mesenchymal transition in patients of pulmonary adenocarcinoma: correlation with cancer stem cell markers and prognosis. , 2015, International journal of clinical and experimental pathology.

[15]  H. Beug,et al.  Molecular requirements for epithelial-mesenchymal transition during tumor progression. , 2005, Current opinion in cell biology.

[16]  S. Miyano,et al.  Twist2 functions as a tumor suppressor in murine osteosarcoma cells , 2013, Cancer science.

[17]  Robert A. Weinberg,et al.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.

[18]  P. Isakson,et al.  c-erbB2-induced epithelial-mesenchymal transition in mammary epithelial cells is suppressed by cell-cell contact and initiated prior to E-cadherin downregulation. , 2005, International journal of oncology.

[19]  Y. Rojanasakul,et al.  Caveolin-1 regulates Mcl-1 stability and anoikis in lung carcinoma cells. , 2012, American journal of physiology. Cell physiology.

[20]  D. Ma,et al.  Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells. , 2010, Biochemical and biophysical research communications.

[21]  F. Tsai,et al.  Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway. , 2009, Lung cancer.

[22]  G. Nuovo,et al.  MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. , 2008, Biochemical and biophysical research communications.

[23]  Steven J. M. Jones,et al.  A Notch‐dependent transcriptional hierarchy promotes mesenchymal transdifferentiation in the cardiac cushion , 2014, Developmental dynamics : an official publication of the American Association of Anatomists.

[24]  J. Mao,et al.  Inhibition of CK2α Down-Regulates Hedgehog/Gli Signaling Leading to a Reduction of a Stem-Like Side Population in Human Lung Cancer Cells , 2012, PloS one.

[25]  J. Guan,et al.  Requirement of Phosphatidylinositol 3-Kinase in Focal Adhesion Kinase-promoted Cell Migration* , 1999, The Journal of Biological Chemistry.

[26]  D. Zhong,et al.  A phase I study of AST1306, a novel irreversible EGFR and HER2 kinase inhibitor, in patients with advanced solid tumors , 2014, Journal of Hematology & Oncology.

[27]  A. Nicholson,et al.  Non-small-cell lung cancer , 2011, The Lancet.

[28]  B. Han,et al.  Wnt signaling regulates the stemness of lung cancer stem cells and its inhibitors exert anticancer effect on lung cancer SPC-A1 cells , 2015, Medical Oncology.

[29]  J. Minna,et al.  Chromosome 19 translocation, overexpression of Notch3, and human lung cancer. , 2000, Journal of the National Cancer Institute.

[30]  Christine M. Fillmore,et al.  The bed and the bugs: interactions between the tumor microenvironment and cancer stem cells. , 2012, Seminars in cancer biology.

[31]  Chih-Hsin Yang,et al.  Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy. , 2008, Lung cancer.

[32]  J. Thiery,et al.  Ras induces NBT-II epithelial cell scattering through the coordinate activities of Rac and MAPK pathways. , 2002, Journal of cell science.

[33]  J. Cherrington,et al.  Src family kinase activity is required for signal tranducer and activator of transcription 3 and focal adhesion kinase phosphorylation and vascular endothelial growth factor signaling in vivo and for anchorage-dependent and -independent growth of human tumor cells. , 2003, Molecular cancer therapeutics.

[34]  Lucila Ohno-Machado,et al.  Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. , 2011, Cancer research.

[35]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature reviews genetics.

[36]  C. Heldin,et al.  Signaling networks guiding epithelial–mesenchymal transitions during embryogenesis and cancer progression , 2007, Cancer science.

[37]  Roman K. Thomas,et al.  A crucial requirement for Hedgehog signaling in small cell lung cancer , 2011, Nature Medicine.

[38]  D. Brazil,et al.  Jagged/Notch signalling is required for a subset of TGFβ1 responses in human kidney epithelial cells. , 2010, Biochimica et biophysica acta.

[39]  Shadan Ali,et al.  Up-Regulation of Sonic Hedgehog Contributes to TGF-β1-Induced Epithelial to Mesenchymal Transition in NSCLC Cells , 2011, PloS one.

[40]  Yoon-La Choi,et al.  Expression of caveolin-1 is associated with poor prognosis of patients with squamous cell carcinoma of the lung. , 2003, Lung cancer.

[41]  Rui Zhang,et al.  MicroRNA-31 inhibits lung adenocarcinoma stem-like cells via down-regulation of MET-PI3K-Akt signaling pathway. , 2016, Anti-cancer agents in medicinal chemistry.

[42]  Won Sang Park,et al.  Immunohistochemical expression of integrins and extracellular matrix proteins in non-small cell lung cancer: correlation with lymph node metastasis. , 2003, Lung cancer.

[43]  Hasseri Halim,et al.  Caveolin-1 regulates metastatic behaviors of anoikis resistant lung cancer cells , 2014, Molecular and Cellular Biochemistry.

[44]  Ido D. Weiss,et al.  CD4+CXCR4highCD69+ T Cells Accumulate in Lung Adenocarcinoma , 2006, The Journal of Immunology.

[45]  Oliver T. Bruns,et al.  Selectins Mediate Small Cell Lung Cancer Systemic Metastasis , 2014, PloS one.

[46]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[47]  Masahiro Fukuoka,et al.  Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS). , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  K. Jones,et al.  Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma. , 2011, Cancer research.

[49]  Rebecca L. Siegel Mph,et al.  Cancer statistics, 2016 , 2016 .

[50]  Y. Rojanasakul,et al.  Nitric oxide induces cancer stem cell-like phenotypes in human lung cancer cells. , 2015, American journal of physiology. Cell physiology.

[51]  B. Yahaya,et al.  Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells , 2015, BMC Cancer.

[52]  H. Yoshiji,et al.  pp60c-src activation in lung adenocarcinoma. , 2003, European journal of cancer.

[53]  H. Werner,et al.  Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling , 2005, Oncogene.

[54]  F. Kisseljov,et al.  Expression of pp60c-src in human small cell and non-small cell lung carcinomas. , 1992, European journal of cancer.

[55]  J. Bai,et al.  Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion , 2009, British Journal of Cancer.

[56]  Jie Huang,et al.  Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy. , 2014, Biochemical and biophysical research communications.

[57]  Liang Xie,et al.  Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. , 2007, Cancer research.

[58]  D. Coppola,et al.  EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer , 2012, Molecular Cancer.

[59]  Y. Soini,et al.  Tissue MMP-2/TIMP-2-complex are better prognostic factors than serum MMP-2, MMP-9 or TIMP-1 in Stage I–III lung carcinoma , 2006 .

[60]  T. Dønnem,et al.  Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer , 2010, Cancer.

[61]  J. Sodroski,et al.  The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry , 1996, Nature.

[62]  Haiping Yang,et al.  JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells. , 2014, International journal of oncology.

[63]  Stuart A. Aaronson,et al.  Exogenous Expression of N-Cadherin in Breast Cancer Cells Induces Cell Migration, Invasion, and Metastasis , 2000, The Journal of cell biology.

[64]  Y. Yarden,et al.  A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor , 1996, Molecular and cellular biology.

[65]  R. Jove,et al.  Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors , 1999, Oncogene.

[66]  Andrew J. Lindsay,et al.  Rab-coupling protein coordinates recycling of α5β1 integrin and EGFR1 to promote cell migration in 3D microenvironments , 2008, The Journal of cell biology.

[67]  T. Dønnem,et al.  The prognostic impact of NF-κB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer , 2008, British Journal of Cancer.

[68]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[69]  D. Sheppard.  Roles of αv integrins in vascular biology and pulmonary pathology , 2004 .

[70]  J. Jung,et al.  Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells , 2013, Oncogene.

[71]  N. Boudreau,et al.  Extracellular matrix and integrin signalling: the shape of things to come. , 1999, The Biochemical journal.

[72]  A. Puisieux,et al.  Metastasis: a question of life or death , 2006, Nature Reviews Cancer.

[73]  Hyeonseok Ko.  Geraniin inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration, invasion and anoikis resistance. , 2015, Bioorganic & medicinal chemistry letters.

[74]  J. Thiery,et al.  Complex networks orchestrate epithelial–mesenchymal transitions , 2006, Nature Reviews Molecular Cell Biology.

[75]  Michael J. McGuire,et al.  A Peptide Selected by Biopanning Identifies the Integrin αvβ6 as a Prognostic Biomarker for Nonsmall Cell Lung Cancer , 2007 .

[76]  Biao He,et al.  Wnt signaling in lung cancer. , 2005, Cancer letters.

[77]  Michael Thomas,et al.  Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. , 2013, The New England journal of medicine.

[78]  F. Hirsch,et al.  HER2/neu expression in malignant lung tumors. , 2002, Seminars in oncology.

[79]  Junchen Wang,et al.  The Side Population in Human Lung Cancer Cell Line NCI-H460 Is Enriched in Stem-Like Cancer Cells , 2012, PloS one.

[80]  P. Chanvorachote,et al.  Roles of caveolin-1 on anoikis resistance in non small cell lung cancer. , 2012, International journal of physiology, pathophysiology and pharmacology.

[81]  Jiyun Yang,et al.  MicroRNA-126 Inhibits Tumor Cell Growth and Its Expression Level Correlates with Poor Survival in Non-Small Cell Lung Cancer Patients , 2012, PloS one.

[82]  Y. Miyagi,et al.  WZ4002, a third-generation EGFR inhibitor, can overcome anoikis resistance in EGFR-mutant lung adenocarcinomas more efficiently than Src inhibitors , 2012, Laboratory Investigation.

[83]  Pierre-Antoine Absil,et al.  Elucidating the Altered Transcriptional Programs in Breast Cancer using Independent Component Analysis , 2007, PLoS Comput. Biol..

[84]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[85]  M. Marra,et al.  A cancer stem cell model for studying brain metastases from primary lung cancer. , 2013, Journal of the National Cancer Institute.

[86]  G. Pelosi,et al.  Alterations of the Notch pathway in lung cancer , 2009, Proceedings of the National Academy of Sciences.

[87]  J. Datta,et al.  IL-6 Promotes Head and Neck Tumor Metastasis by Inducing Epithelial–Mesenchymal Transition via the JAK-STAT3-SNAIL Signaling Pathway , 2011, Molecular Cancer Research.

[88]  Narumol Bhummaphan,et al.  Gigantol Suppresses Cancer Stem Cell-Like Phenotypes in Lung Cancer Cells , 2015, Evidence-based complementary and alternative medicine : eCAM.

[89]  Y. Miller,et al.  Analysis of c-ErbB1/Epidermal Growth Factor Receptor and c-ErbB2/HER-2 Expression in Bronchial Dysplasia: Evaluation of Potential Targets for Chemoprevention of Lung Cancer , 2006, Clinical Cancer Research.

[90]  B. Bao,et al.  Inhibition of Hedgehog signaling sensitizes NSCLC cells to standard therapies through modulation of EMT-regulating miRNAs , 2013, Journal of Hematology & Oncology.

[91]  Stephen Lam,et al.  Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. , 2007, Cancer research.

[92]  Junwen Wang,et al.  Lung cancer tumorigenicity and drug resistance are maintained through ALDHhiCD44hi tumor initiating cells , 2013, Oncotarget.

[93]  A. Sihoe,et al.  Src Promotes Survival and Invasion of Lung Cancers with Epidermal Growth Factor Receptor Abnormalities and Is a Potential Candidate for Molecular-Targeted Therapy , 2009, Molecular Cancer Research.

[94]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[95]  Susanna M Cramb,et al.  The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[96]  W. Han,et al.  Wnt/β-catenin signaling pathway in lung cancer stem cells is a potential target for the development of novel anticancer drugs. , 2015, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[97]  G. Goodall,et al.  The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.

[98]  L. Spaggiari,et al.  Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-β–SMAD3 pathway in non-small cell lung adenocarcinoma , 2014, Proceedings of the National Academy of Sciences.

[99]  N. Kohno,et al.  Significance of Integrin α5 Gene Expression as a Prognostic Factor in Node-negative Non-Small Cell Lung Cancer , 2000 .

[100]  Kazuhisa Takahashi,et al.  Hypoxia Increases Gefitinib-Resistant Lung Cancer Stem Cells through the Activation of Insulin-Like Growth Factor 1 Receptor , 2014, PloS one.

[101]  Frank McCormick,et al.  Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. , 2004, Genes & development.

[102]  Hua Wu,et al.  Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application , 2014, Journal of Hematology & Oncology.

[103]  B. Hinz,et al.  Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix , 2007, The Journal of cell biology.

[104]  R. Strieter.  Chemokines: Not just leukocyte chemoattractants in the promotion of cancer , 2001, Nature Immunology.

[105]  C. Gahmberg,et al.  PKCɛ Regulation of an α5 Integrin–ZO-1 Complex Controls Lamellae Formation in Migrating Cancer Cells , 2009, Science Signaling.

[106]  D. Beer,et al.  C-Reactive Protein Downregulates TRAIL Expression in Human Peripheral Monocytes via an Egr-1–Dependent Pathway , 2013, Clinical Cancer Research.

[107]  F. Cappuzzo,et al.  Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer , 2009, Oncogene.

[108]  K. Moon,et al.  Expression of caveolin-1 in pleomorphic carcinoma of the lung is correlated with a poor prognosis. , 2005, Anticancer research.

[109]  K. Yasumoto,et al.  Stimulation of {beta}1 Integrin Down-Regulates ICAM-1 Expression and ICAM-1-dependent Adhesion of Lung Cancer Cells through Focal Adhesion Kinase , 2001 .

[110]  Liwen Liu,et al.  Notch3 is important for TGF-β-induced epithelial–mesenchymal transition in non-small cell lung cancer bone metastasis by regulating ZEB-1 , 2014, Cancer Gene Therapy.

[111]  W. Gradishar,et al.  ERK-regulated αB-Crystallin Induction by Matrix Detachment Inhibits Anoikis and Promotes Lung Metastasis in vivo , 2015, Oncogene.

[112]  Sun-Mi Park,et al.  The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. , 2008, Genes & development.

[113]  J. Bai,et al.  Inhibitory role of focal adhesion kinase on anoikis in the lung cancer cell A549 , 2008, Cell biology international.

[114]  S. Eccles,et al.  Metastasis: recent discoveries and novel treatment strategies , 2007, The Lancet.

[115]  Diane D. Liu,et al.  Epithelial-to-Mesenchymal Transition in the Development and Progression of Adenocarcinoma and Squamous Cell Carcinoma of the Lung , 2009, Modern Pathology.

[116]  K. O'Byrne,et al.  Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[117]  E. Wang,et al.  Wnt3a increases the metastatic potential of non-small cell lung cancer cells in vitro in part via its upregulation of Notch3. , 2015, Oncology reports.

[118]  M. Burdick,et al.  The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases. , 2003, American journal of respiratory and critical care medicine.

[119]  Karen D. Cowden Dahl,et al.  Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. , 2008, Cancer research.

[120]  D. Nowak,et al.  Elevated level of circulating matrix metalloproteinase-9 in patients with lung cancer. , 2001, Respiratory medicine.

[121]  Pan‐Chyr Yang,et al.  Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. , 2002, The American journal of pathology.

[122]  J. Turkson,et al.  Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells , 2003, Oncogene.

[123]  Michael Dean,et al.  Tumour stem cells and drug resistance , 2005, Nature Reviews Cancer.

[124]  S. Frisch,et al.  Disruption of epithelial cell-matrix interactions induces apoptosis , 1994, The Journal of cell biology.

[125]  Xueyan Zhang,et al.  Wnt signaling regulation of stem-like properties in human lung adenocarcinoma cell lines , 2015, Medical Oncology.

[126]  Lei Chen,et al.  Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer , 2014, Journal of Neuro-Oncology.

[127]  M. Papotti,et al.  β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells , 2011, Oncogene.

[128]  Monilola A. Olayioye,et al.  The ErbB signaling network: receptor heterodimerization in development and cancer , 2000, The EMBO journal.

[129]  P. Bunn,et al.  Recent clinical advances in lung cancer management. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.